StreetInsider.com • August 8, 2019, 6:40 am
AHF Challenges Gilead to Charge $1 per-pill for Descovy for PrEP Use StreetInsider.comFDA advisory panel recommends FDA approval of Gilead Sciences’ AIDS treatment medication Discovy (emtricitabine…
The Market Plan • August 8, 2019, 6:15 am
Enteral Nutrition Pumps Market Forecast to 2024 Explored in Latest Research The Market PlanEnteral nutrition pumps are devices used to deliver nutritive food directly to a patient’s stomach or…
Austin Chronicle • August 8, 2019, 5:02 am
The History of the LGBTQ Movement in Austin Austin ChronicleOn June 26, 1976, Austin’s LGBTQ community, including the Austin Lesbian Organization (pictured), marched through Downtown in Austin’s…
McKnight’s Long Term Care News • August 7, 2019, 9:09 pm
Residents will want 6,000 fewer nursing home beds in CT by 2040, report asserts – News McKnight’s Long Term Care NewsA government-sanctioned report predicts Connecticut residents will demand about…
Camden Advertiser • August 8, 2019, 5:00 am
Life is better with an assistance dog Camden AdvertiserInternational Assistance Dog Week highlights the positive impact these dogs make.
The post AHF Challenges Gilead to Charge $1 per-pill for Descovy for PrEP Use – StreetInsider.com appeared first on Home Living Aid.
via Home Living Aid https://www.homelivingaid.com/home-living-aid-news/ahf-challenges-gilead-to-charge-1-per-pill-for-descovy-for-prep-use-streetinsider-com/